AGL vs CVS
AGL: Agilon empowers primary care physicians to take financial and clinical risk for managing total healthcare costs under Medicare capitation, using technology and data to drive quality and profitability. CVS: CVS Health is an integrated health care giant combining extensive retail pharmacy networks, pharmacy benefits management, and comprehensive health insurance offerings to simplify consumer health experiences.
Side-by-side fundamentals
| Metric | AGL | CVS | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $119.88 | $108.08 | |
| Market cap as of 2026-07-23 | $2.0B | $140.4B | |
| P/E as of 2026-07-23 | n/a | 47.90 | |
| PEG as of 2026-07-23 | -0.12 | 3.33 | AGL lower |
| Net margin as of 2026-07-23 | -6.1% | +0.7% | CVS higher |
| Gross margin as of 2026-07-23 | -0.4% | +13.9% | CVS higher |
| Operating margin as of 2026-07-23 | -7.5% | +1.6% | CVS higher |
| ROE as of 2026-07-23 | -138.6% | +3.9% | CVS higher |
| ROA as of 2026-07-23 | -23.3% | +1.1% | CVS higher |
| Debt / equity as of 2026-07-23 | 0.17 | 0.81 | AGL lower |
| Revenue growth (YoY) as of 2026-07-23 | -2.8% | +7.6% | CVS higher |
| Revenue CAGR (3y) SEC XBRL | +35.4% | +7.6% | AGL higher |
| Dividend yield as of 2026-07-23 | n/a | +2.4% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-23 | 3.03 | 0.59 | |
| 1-year return as of 2026-07-22 close | +135.1% | +76.9% | AGL higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.